Literature DB >> 16003298

Pharmacokinetics of glimepiride and cytochrome P450 2C9 genetic polymorphisms.

Rui Wang, Kun Chen, Si-yuan Wen, Jian Li, Sheng-qi Wang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16003298     DOI: 10.1016/j.clpt.2005.03.008

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  16 in total

Review 1.  Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance.

Authors:  Julia Kirchheiner; Ivar Roots; Mark Goldammer; Bernd Rosenkranz; Jürgen Brockmöller
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 2.  The role of pharmacogenetics in drug disposition and response of oral glucose-lowering drugs.

Authors:  N van Leeuwen; J J Swen; H-J Guchelaar; L M 't Hart
Journal:  Clin Pharmacokinet       Date:  2013-10       Impact factor: 6.447

3.  Population pharmacokinetic analysis of glimepiride with CYP2C9 genetic polymorphism in healthy Korean subjects.

Authors:  Hee-Doo Yoo; Mi-Suk Kim; Hea-Young Cho; Yong-Bok Lee
Journal:  Eur J Clin Pharmacol       Date:  2011-04-08       Impact factor: 2.953

Review 4.  Genetics of drug response in type 2 diabetes.

Authors:  Ivan Tkáč
Journal:  Curr Diab Rep       Date:  2015-07       Impact factor: 4.810

Review 5.  Individualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data.

Authors:  Gaia Chiara Mannino; Giorgio Sesti
Journal:  Mol Diagn Ther       Date:  2012-10       Impact factor: 4.074

6.  Impact of clinical factors and CYP2C9 variants for the risk of severe sulfonylurea-induced hypoglycemia.

Authors:  Andreas Holstein; Michael Hahn; Olaf Patzer; Angela Seeringer; Peter Kovacs; Julia Stingl
Journal:  Eur J Clin Pharmacol       Date:  2011-01-07       Impact factor: 2.953

7.  Mild hypoglycaemic attacks induced by sulphonylureas related to CYP2C9, CYP2C19 and CYP2C8 polymorphisms in routine clinical setting.

Authors:  Osman Gökalp; Arzu Gunes; Hakan Cam; Erkan Cure; Osman Aydın; Mehmet Numan Tamer; Maria Gabriella Scordo; Marja-Liisa Dahl
Journal:  Eur J Clin Pharmacol       Date:  2011-06-21       Impact factor: 2.953

Review 8.  Pharmacogenetics of glucose-lowering drug treatment: a systematic review.

Authors:  Ozlem Bozkurt; Anthonius de Boer; Diederick E Grobbee; Eibert R Heerdink; Huib Burger; Olaf H Klungel
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

Review 9.  Pharmacogenetics in diabetes.

Authors:  Ewan R Pearson
Journal:  Curr Diab Rep       Date:  2009-04       Impact factor: 4.810

10.  Mechanism-based pharmacokinetic modeling to evaluate transporter-enzyme interplay in drug interactions and pharmacogenetics of glyburide.

Authors:  Manthena V S Varma; Renato J Scialis; Jian Lin; Yi-An Bi; Charles J Rotter; Theunis C Goosen; Xin Yang
Journal:  AAPS J       Date:  2014-05-17       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.